// App-Quantinova.ai

e21653 : A prospective, real-world study of treatment patterns in early-stage breast cancer (ESBC) patients (pts) at high risk for febrile neutropenia (FN).

Researchers

Presenter

  • Spyridon Tzivelekis

Principal Investigators

  • Scott Stryker

  • Zandra Karina Klippel

  • Wayne Sheldon

  • Yanli Li

  • David Chandler

  • Arun Nagarajan

  • Maureen Reiner

Medical Centers

  • Amgen Inc, Thousand Oaks, CA

  • Amgen Inc, South San Francisco, CA

  • Charleston Area Medical Center, David Lee Cancer Center, Charleston, WV

Locations

  • United States

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Breast cancer

  • Neutropenia

  • Solid malignancies

  • Sepsis

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved